NEW YORK – Researchers at the Children's Hospital of Philadelphia (CHOP) are advocating for increased NTRK fusion testing in pediatric cancer patients after finding in a recent study that such alterations tend to occur more frequently in children than adults, and that knowledge of such fusions can help definitively diagnose patients and inform therapeutic strategy in earlier disease settings.
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.